1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
(
- Contribution to journal › Article
- 2018
-
Mark
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma : Results from the collaboration to collect autologous transplant outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT chronic malignancies working party
(
- Contribution to journal › Article
-
Mark
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(Immuno)therapy
(
- Contribution to journal › Letter
- 2017
-
Mark
Chronic lymphocytic leukemia with mutated IGHV4-34 receptors : Shared and distinct immunogenetic features and clinical outcomes
(
- Contribution to journal › Article
- 2015
-
Mark
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
(
- Contribution to journal › Article
- 2014
-
Mark
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
(
- Contribution to journal › Article
- 2012
-
Mark
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
(
- Contribution to journal › Article
- 2008
-
Mark
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
(
- Contribution to journal › Article